Glycan antagonists and inhibitors: A fount for drug discovery

Critical Reviews in Biochemistry and Molecular Biology

Volumn 42, Issue 6, 2007, Pages 481-515

  Brown, Jillian R ^a   Crawford, Brett E ^a   Esko, Jeffrey D ^b  

^a Zacharon Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Carbohydrates; Glycans; Glycosylation; Inhibitors; Therapeutics

Indexed keywords

ACARBOSE; AGALSIDASE BETA; ANTINEOPLASTIC AGENT; ANTITHROMBOCYTIC AGENT; ASTENOSE; BIMOSIAMOSE; CARDIOVASCULAR AGENT; CASTANOSPERMINE 6 BUTYRATE; CUMULASE; CYLEXIN; ELAPRASE; EPRODISATE; GCS 100; GD 0039; GENZ 112638; GH 9001; GLYCAN; HEMATOLOGIC AGENT; HEPARIN; HEPARIN LYASE; HOMOTAURINE; HULUC 63; HYALURONIC ACID; IDURONATE 2 SULFATASE; IMIGLUCERASE; LARONIDASE; M 118; MIGLUSTAT; N ACETYLGALACTOSAMINE 4 SULFATASE; OGT 719; OSELTAMIVIR; PI 88; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZANAMIVIR; ZP 103;

ACUTE CORONARY SYNDROME; ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ASTHMA; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CARBOHYDRATE SYNTHESIS; CELL ISOLATION; CLINICAL TRIAL; DRUG SYNTHESIS; EMBRYO DEVELOPMENT; FABRY DISEASE; GAUCHER DISEASE; GLYCOGEN STORAGE DISEASE TYPE 2; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTER SYNDROME; INFLUENZA; LIVER CANCER; METABOLIC DISORDER; METASTASIS; MULTIPLE MYELOMA; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; PRIORITY JOURNAL; REPERFUSION INJURY; RESTENOSIS; REVIEW; SPINAL CORD INJURY; WOUND HEALING;

ANIMALS; DRUG DESIGN; GLYCOPROTEINS; GLYCOSPHINGOLIPIDS; GLYCOSYLPHOSPHATIDYLINOSITOLS; HUMANS; POLYSACCHARIDES;

ANIMALIA;

EID: 36849092506     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409230701751611     Document Type: Review

References (322)

1. Abe, A., Inokuchi, J., Ji mbo, M., Shimeno, H., Nagamatsu, A., Shayman, J.A., Shukla, G.S., and Radin, N.S. 1992. Improved inhibitors of glucosylceramide synthase. J Biochem (Tokyo) 111:191-196.
2. Abe, A., and Shayman, J. A. 1998. Purification and characterization of 1-O-acylceramide synthase, a novel phospholipase A2 with transacylase activity. J Biol Chem 273:8467-8474.
3. Abe, A., Arend, L.J., Lee, L., Lingwood, C., Brady, R.O., and Shayman, J.A. 2000. Glycosphingolipid depletion in Fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase. Kidney Int 57:446-454.
4. Acres, B., and Limacher, J.M. 2005. MUC1 as a target antigen for cancer immunotherapy. Expert Rev Vaccines 4:493-502.
5. Adamia, S., Maxwell, C.A., and Pilarski, L. M. 2005. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 5:3-14.
6. Akimoto, Y., Hart, G.W., Wells, L., Vosseller, K., Yamamoto, K., Munetomo, E., Ohara-Imaizumi, M., Nishiwaki, C., Nagamatsu, S., Hirano, H. et al. 2007. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats. Glycobiology 17:127-140.
7. Allavena, P., Chieppa, M., Monti, P., and Piemonti, L. 2004. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol 24:179-192.
8. Andrali, S.S., Qian, Q., and Ozcan, S. 2007. Glucose mediates the translocation of neuroD1 by O-linked glycosylation. J Biol Chem 282:15589-15596.
9. Arias, E.B., Kim, J., and Cartee, G.D. 2004. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle. Diabetes 53:921-930.
10. Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J.R., and Yamada, Y. 1999. Perlecan is essential for cartilage and cephalic development. Nat Genet 23:354-358.
11. Armstrong, J.I., Portley, A.R., Chang, Y.T., Nierengarten, D.M., Cook, B. N., Bowman, K. G., Bishop, A., Gray, N. S., Shokat, K. M., Schultz, P. G. et al. 2000. Discovery of carbohydrate sulfotransferase inhibitors from a kinase-directed library. Angew Chem (Int Edit). 39:1303-1306.
12. Arnold, C.S., Johnson, G.V., Cole, R.N., Dong, D.L., Lee, M., and Hart, G.W. 1996. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem 271:28741-28744.
13. Asano, N., Nash, R.J., Molyneux, R.J., and Fleet, G.W.J. 2000. Sugarmimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron: Asymmetry 11:1645-1680.
14. Asano, N. 2003. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 13:93R-104R.
15. Baeuerle, P.A., and Huttner, W.B. 1986. Chlorate - a potent inhibitor of protein sulfation in intact cells. Biochem Biophys Res Commun 141:870-877.
16. Barresi, R., and Campbell, K.P. 2006. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119:199-207.
17. Batova, A., Kamps, A., Gillies, S.D., Reisfeld, R.A., and Yu, A.L. 1999. The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro. Clin Cancer Res 5:4259-4263.
18. Beeh, K.M., Beier, J., Meyer, M., Buhl, R., Zahlten, R., and Wolff, G. 2006. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial. Pulm Pharmacol Ther 19:233-241.
19. Belting, M., Borsig, L., Fuster, M.M., Brown, J.R., Persson, L., Fransson, L. ° A., and Esko, J. D. 2002. Tumor attenuation by combined heparan sulfate and polyamine depletion. Proc Natl Acad Sci USA 99:371-376.
20. Berkin, A., Szarek, W.A., and Kisilevsky, R. 2005. Biological evaluation of a series of 2-acetamido-2-deoxy-D: -glucose analogs towards cellular glycosaminoglycan and protein synthesis in vitro. Glycoconj J 22:443-451.
21. Best, M.D., Brik, A., Chapman, E., Lee, L.V., Cheng, W.C., and Wong, C.H. 2004. Rapid discovery of potent sulfotransferase inhibitors by diversity-oriented reaction in microplates followed by in situ screening. Chembiochem 5:811-819.
22. Bishop, J.R., and Gagneux, P. 2007. Evolution of carbohydrate antigens-microbial forces shaping host glycomes? Glycobiology 17:23R-34R.
23. Bone, W., Walden, C.M., Fritsch, M., Voigtmann, U., Leifke, E., Gottwald, U., Boomkamp, S., Platt, F.M., and van der Spoel, A.C. 2007. The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study. Reprod Biol Endocrinol 5:1-13.
24. Borsig, L., Wong, R., Feramisco, J., Nadeau, D.R., Varki, N.M., and Varki, A. 2001. Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98:3352-3357.
25. Botta, M., Manetti, F., and Corelli, F. 2000. Fibroblast growth factors and their inhibitors. Curr Pharm Des 6:1897-1924.
26. Bovin, N.V., Tuzikov, A.B., Chinarev, A.A., and Gambaryan, A.S. 2004. Multimeric glycotherapeutics: new paradigm. Glycoconj J 21:471-478.
27. Brekken, C., Hjelstuen, M.H., Bruland, O.S., and de Lange Davies, C. 2000. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts. Anticancer Res 20:3513-3519.
28. Brockhausen, I., Carran, J., McEleney, K., Lehotay, M., Yang, X., Yin, L., and Anastassiades, T. 2005. N-Acyl derivatives of glucosamine as acceptor substrates for galactosyltransferase from bone and cartilage cells. Carbohydr Res 340:1997-2003.
29. Brockhausen, I. 2006. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7:599-604.
30. Brockhausen, I., Benn, M., Bhat, S., Marone, S., Riley, J.G., Montoya-Peleaz, P., Vlahakis, J. Z., Paulsen, H., Schutzbach, J.S., and Szarek, W.A. 2006. UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase-a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme. Glycoconj J 23:525-541.
31. Brodsky, R.A., and Hu, R. 2006. PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis. Leuk Lymphoma 47:1215-1221.
32. Brooks, S.A., Schumacher, U., and Dweck, M.V. 2002. Functional and Molecular Glycobiology. London: Taylor & Francis Ltd. London.
33. Brown, J. R., Fuster, M., Whisenant, T., and Esko, J. D. 2003. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys. J Biol Chem 278:23352-23359.
34. Brown, J. R., Fuster, M. M., and Esko, J. D. 2003. Glycoside primers and inhibitors of glycosylation. In: Carbohydrate Based Drug Discovery, Wong, C.-H., Ed., Weinheim: Wiley VCH, 883-898.
35. Brown, J. R., Fuster, M. M., Li, R., Varki, N., Glass, C. A., and Esko, J. D. 2006. A disaccharide-based inhibitor of glycosylation attenuates metastatic tumor cell dissemination. Clin Cancer Res 12:2894-2901.
36. Brown, J. R., Nishimura, Y., and Esko, J. D. 2006. Synthesis and biological evaluation of gem-diamine 1-N-iminosugars related to L-iduronic acid as inhibitors of heparan sulfate 2-O-sulfotransferase. Bioorg Med Chem Lett 16:532-536.
37. Brown, J. R., Yang, F., Sinha, A., Ramakrishnan, B., Qasba, P. K., and Esko, J. D. 2008. Sugar-related analogs inhibit β4galactosyltransferase-1 and block essential protein-carbohydrate interactions involved in metastasis. Nature Chem Biol, (submitted).
38. Bryan, M.C., Lee, L.V., and Wong, C.H. 2004. High-throughput identification of fucosyltransferase inhibitors using carbohydrate microarrays. Bioorg Med Chem Lett 14:3185-3188.
39. Burkart, M.D., Vincent, S.P., Duffels, A., Murray, B.W., Ley, S.V., and Wong, C.H. 2000. Chemo-enzymatic synthesis of fluorinated sugar nucleotide: useful mechanistic probes for glycosyltransferases. Bioorg Med Chem 8:1937-1946.
40. Caggiano, A.O., Zimber, M.P., Ganguly, A., Blight, A.R., and Gruskin, E.A. 2005. Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord. J Neurotrauma 22:226-239.
41. Chatterjee, S., Cleveland, T., Shi, W.Y., Inokuchi, J., and Radin, N.S. 1996. Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase. Glycoconj J 13:481-486.
42. Chauhan, D., Li, G., Podar, K., Hideshima, T., Neri, P., He, D., Mitsiades, N., Richardson, P., Chang, Y., Schindler, J. et al. 2005. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells. Cancer Res 65:8350-8358.
43. Chen, M., Bridges, A., and Liu, J. 2006. Determination of the substrate specificities of N-acetyl-d-glucosaminyltransferase. Biochemistry 45:12358-12365.
44. Chhabra, S.R., Rahim, A.S., and Kellam, B. 2003. Recent progress in the design of selectin inhibitors. Mini Rev Med Chem 3:679-687.
45. Chiavegatto, S., Sun, J., Nelson, R.J., and Schnaar, R.L. 2000. A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice. Exp Neurol 166:227-234.
46. Choi, S., Clements, D.J., Pophristic, V., Ivanov, I., Vemparala, S., Bennett, J.S., Klein, M. L., Winkler, J.D., and DeGrado, W.F. 2005. The design and evaluation of heparin-binding foldamers. Angew Chem Int Ed Engl 44:6685-6689.
47. Chung, S.J., Takayama, S., and Wong, C.H. 1998. Acceptor substrate-based selective inhibition of galactosyltransferases. Bioorg Med Chem Lett 8:3359-3364.
48. Clark, C.C., Richards, C.F., Pacifici, M., and Iozzo, R.V. 1987. The effects of 6-Diazo-5-oxo-L-norleucine, a glutamine analogue, on the structure of the major cartilage proteoglycan synthesized by cultured chondrocytes. J Biol Chem 262:10229-10238.
49. Compain, P., and Martin, O.R. 2001. Carbohydrate mimetics-based glycosyltransferase inhibitors. Bioorg Med Chem. 9:3077-3092.
50. Conrad, H.E. 1998. Heparin-Binding Proteins. San Diego: Academic Press.
51. Crocker, P.R., Paulson, J.C., and Varki, A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol 7:255-266.
52. Crossman, A., Jr., Brimacombe, J.S., Ferguson, M.A., and Smith, T.K. 1999. Synthesis of some second-generation substrate analogues of early intermediates in the biosynthetic pathway of glycosylphosphatidylinositol membrane anchors. Carbohydr Res 321:42-51.
53. Dauphinee, S.M., Ma, M., and Too, C.K. 2005. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells. J Cell Biochem 96:579-588.
54. Degroote, S., Wolthoorn, J., and van Meer, G. 2004. The cell biology of glycosphingolipids. Semin Cell Dev Biol 15:375-387.
55. Deng, W., Li, R., and Ladisch, S. 2000. Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst 92:912-917.
56. Dennis, J.W., White, S.L., Freer, A.M., and Dime, D. 1993. Carbonoyloxy analogs of the anti-metastatic drug swainsonine. Activation in tumor cells by esterases. Biochem Pharmacol 46:1459-1466.
57. Descheny, L., Gainers, M.E., Walcheck, B., and Dimitroff, C.J. 2006. Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of N-acetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand. J Invest Dermatol 126:2065-2073.
58. Dietrich, C.P., Nader, H.B., Buonassisi, V., and Colburn, P. 1988. Inhibition of synthesis of heparan sulfate by selenate: possible dependence on sulfation for chain polymerization. Faseb J 2:56-59.
59. Dimitroff, C.J., Sharma, A., and Bernacki, R. J. 1998. Cancer metastasis: a search for therapeutic inhibition. Cancer Invest 16:279-290.
60. Dimitroff, C.J., Bernacki, R.J., and Sackstein, R. 2003. Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood 101:602-610.
61. Dimitroff, C.J., Kupper, T.S., and Sackstein, R. 2003. Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. J Clin Invest 112:1008-1018.
62. Doering, T.L., Raper, J., Buxbaum, L.U., Adams, S.P., Gordon, J.I., Hart, G.W., and Englund, P.T. 1991. An analog of myristic acid with selective toxicity for African trypanosomes. Science 252:1851-1854.
63. Doering, T.L., Pessin, M.S., Hart, G.W., Raben, D.M., and Englund, P.T. 1994. The fatty acids in unremodelled trypanosome glycosylphosphatidylinositols. Biochem J 299:741-746.
64. Dong, D.L., and Hart, G.W. 1994. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem 269:19321-19330.
65. Dorfmueller, H.C., Borodkin, V.S., Schimpl, M., Shepherd, S.M., Shpiro, N.A., and van Aalten, D.M. 2006. GlcNAcstatin: a picomolar, selective O-GlcNAcase inhibitor that modulates intracellular O-glcNAcylation levels. J Am Chem Soc 128:16484-16485.
66. Durrant, L.G., Harding, S.J., Green, N.H., Buckberry, L.D., and Parsons, T. 2006. A new anticancer glycolipid monoclonal antibody, SC104, which directly induces tumor cell apoptosis. Cancer Res 66:5901-5909.
67. Dwek, R.A., Butters, T.D., Platt, F.M., and Zitzmann, N. 2002. Targeting glycosylation as a therapeutic approach. Nat Rev Drug Discov 1:65-75.
68. Elbein, A.D. 1987. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu Rev Biochem 56:497-534.
69. Elbein, A.D. 1991. Glycosidase inhibitors: Inhibitors of N-linked oligosaccharide processing. FASEB J 5:3055-3063.
70. Ellies, L.G., Tsuboi, S., Petryniak, B., Lowe, J.B., Fukuda, M., and Marth, J.D. 1998. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity 9:881-890.
71. Ellies, L.G., Ditto, D., Levy, G.G., Wahrenbrock, M., Ginsburg, D., Varki, A., Le, D.T., and Marth, J.D. 2002. Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA 99:10042-10047.
72. Elson-Schwab, L., Garner, O.B., Schuksz, M., Crawford, B.E., Esko, J.D., and Tor, Y. 2007. Guanidinylated neomycin delivers large, bioactive cargo into cells through a heparan sulfate-dependent pathway. J Biol Chem 282:13585-13591.
73. Endo, T., and Manya, H. 2006. O-mannosylation in mammalian cells. Methods Mol Biol 347:43-56.
74. Esko, J.D., Rostand, K.S., and Weinke, J.L. 1988. Tumor formation dependent on proteoglycan biosynthesis. Science 241:1092-1096.
75. Esko, J. D., and Lindahl, U. 2001. Molecular diversity of heparan sulfate. J Clin Invest 108:169-173.
76. Etchison, J.R., Srikrishna, G., and Freeze, H.H. 1995. A novel method to co-localize glycosaminoglycan-core oligosaccharide glycosyltransferases in rat liver Golgi. Co-localization of galactosyltransferase I with a sialyltransferase. J Biol Chem 270:756-764.
77. Fang, B., and Miller, M.W. 2001. Use of galactosyltransferase to assess the biological function of O-linked N-acetyl-d-glucosamine: a potential role for O-GlcNAc during cell division. Exp Cell Res 263:243-253.
78. Fawcett, J.W. 2006. Overcoming inhibition in the damaged spinal cord. J Neurotrauma 23:371-383.
79. Ferguson, M.A., Brimacombe, J.S., Brown, J.R., Crossman, A., Dix, A., Field, R.A., Guther, M.L., Milne, K.G., Sharma, D.K., and Smith, T.K. 1999. The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness. Biochim Biophys Acta 1455:327-340.
80. Ferguson, M.A. 2000. Glycosylphosphatidylinositol biosynthesis validated as a drug target for African sleeping sickness. Proc Natl Acad Sci USA 97:10673-10675.
81. Ferguson, M.A.J. 1999. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Sci 112:2799-2809.
82. Fischl, M.A., Resnick, L., Coombs, R., Kremer, A.B., Pottage, J.C., Jr., Fass, R.J., Fife, K. H., Powderly, W. G., Collier, A. C., Aspinall, R. L. et al. 1994. The safety and efficacy of combination N-butyldeoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1 infection and 200-500 CD4 cells/mm3. J Acquir Immune Defic Syndr 7:139-147.
83. Fredman, P., Hedberg, K., and Brezicka, T. 2003. Gangliosides as therapeutic targets for cancer. BioDrugs 17:155-167.
84. Freeze, H.H., Sampath, D., and Varki, A. 1993. Alpha- and beta-xylosides alter glycolipid synthesis in human melanoma and Chinese hamster ovary cells. J Biol Chem 268:1618-1627.
85. Fritz, T.A., Lugemwa, F.N., Sarkar, A.K., and Esko, J.D. 1994. Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure. J Biol Chem 269:300-307.
86. Fritz, T.A., Agrawal, P.K., Esko, J.D., and Krishna, N.R. 1997. Partial purification and substrate specificity of heparan sulfate α-N- acetylglucosaminyltransferase .1. Synthesis, NMR spectroscopic characterization and in vitro assays of two aryl tetrasaccharides. Glycobiology 7:587-595.
87. Fuchs, S.M., and Raines, R.T. 2004. Pathway for polyarginine entry into mammalian cells. Biochemistry 43:2438-2444.
88. Fukuda, M. 2002. Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acta 1573:394-405.
89. Funderburgh, J.L. 2000. Keratan sulfate: structure, biosynthesis, and function. Glycobiology 10:951-958.
90. Funderburgh, J.L. 2002. Keratan sulfate biosynthesis. IUBMB Life 54:187-194.
91. Fuster, M.M., Brown, J.R., Wang, L., and Esko, J.D. 2003. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res 63:2775-2781.
92. Fuster, M.M., Wang, L., Castagnola, J., Sikora, L., Reddi, K., Lee, P.H.A., Radek, K., Schuksz, M., Bishop, J.R., Gallo, R.L. et al. 2007. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis. J Cell Biol 177:539-549.
93. Gabius, H.J., André, S., Kaltner, H., and Siebert, H.C. 2002. The sugar code: functional lectinomics. Biochim Biophys Acta Gen Subj 1572:165-177.
94. Gao, Y., Wells, L., Comer, F.I., Parker, G.J., and Hart, G.W. 2001. Dynamic O-glycosylation of nuclear and cytosolic proteins - Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J Biol Chem 276:9838-9845.
95. Gilewski, T., Ragupathi, G., Bhuta, S., Williams, L.J., Musselli, C., Zhang, X.F., Bornmann, W. G., Spassova, M., Bencsath, K. P., Panageas, K. S. et al. 2001. Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial. Proc Natl Acad Sci USA 98:3270-3275.
96. Gilewski, T.A., Ragupathi, G., Dickler, M., Powell, S., Bhuta, S., Panageas, K., Koganty, R. R., Chin-Eng, J., Hudis, C., Norton, L. et al. 2007. Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21. Clin Cancer Res 13:2977-2985.
97. Granovsky, M., Fata, J., Pawling, J., Muller, W.J., Khokha, R., and Dennis, J.W. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 6:306-312.
98. Gross, B.J., Kraybill, B.C., and Walker, S. 2005. Discovery of O-GlcNAc transferase inhibitors. J Am Chem Soc 127:14588-14589.
99. Guthmann, M.D., Castro, M.A., Cinat, G., Venier, C., Koliren, L., Bitton, R. J., Vazquez, A.M., and Fainboim, L. 2006. Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients. J Immunother (1997) 29:215-223.
100. Haltiwanger, R.S., Grove, K., and Philipsberg, G.A. 1998. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J Biol Chem 273:3611-3617.
101. Haltiwanger, R.S., and Lowe, J.B. 2004. Role of Glycosylation in Development. Annu Rev Biochem 73:491-537.
102. Hang, H.C., Yu, C., Ten Hagen, K.G., Tian, E., Winans, K.A., Tabak, L.A., and Bertozzi, C. R. 2004. Small molecule inhibitors of mucin-type O-linked glycosylation from a uridine-based library. Chem Biol 11:337-345.
103. Hanisch, F.A. 2001. O-glycosylation of the mucin type. Biol Chem 382:143-149.
104. Harper, J.R., Quaranta, V., and Reisfeld, R.A. 1986. Ammonium chloride interferes with a distinct step in the biosynthesis and cell surface expression of human melanoma-type chondroitin sulfate proteoglycan. J Biol Chem 261:3600-3606.
105. Hashimoto, H., Endo, T., and Kajihara, Y. 1997. Synthesis of the first tricomponent bisubstrate analogue that exhibits potent inhibition against GlcNAc:β-1,4-galactosyltransferase. J Org Chem 62:1914-1915.
106. Hayashi, T., Murray, B.W., Wang, R., and Wong, C.H. 1997. A chemoenzymatic synthesis of UDP-(2-deoxy-2-fluoro)-galactose and evaluation of its interaction with galactosyltransferase. Bioorg Med Chem 5:497-500.
107. Hebert, L.F., Jr., Daniels, M.C., Zhou, J., Crook, E.D., Turner, R.L., Simmons, S.T., Neidigh, J.L., Zhu, J.S., Baron, A.D., and McClain, D.A. 1996. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-936.
108. Hekman, A. 1971. Association of lactoferrin with other proteins, as demonstrated by changes in electrophoretic mobility. Biochim Biophys Acta 251:380-387.
109. Heldin, C.H., Rubin, K., Pietras, K., and Ostman, A. 2004. High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 4:806-813.
110. Helland, A.C., Hindsgaul, O., Palcic, M.M., Stults, C.L., and Macher, B. A. 1995. Methyl 3-amino-3-deoxy-beta-D-galactopyranosyl-(1→4)-2-acetamido- 2- deoxy-beta-D-glucopyranoside: an inhibitor of UDP-D-galactose: beta-D- galactopyranosyl-(1→4)-2-acetamido-2-deoxy-D-glucose (1→3)-alpha-D- galactopyranosyltransferase. Carbohydr Res 276:91-98.
111. Hindsgaul, O. 1991. Synthesis of carbohydrates for applications in glycobiology. Semin Cell Biol 2:319-326.
112. Hindsgaul, O., Kaur, K.J., Srivastava, G., Blaszczyk-Thurin, M., Crawley, S.C., Heerze, L.D., and Palcic, M.M. 1991. Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases. J Biol Chem 266:17858-17862.
113. Hinou, H., Sun, X.L., and Ito, Y. 2003. Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases. J Org Chem 68:5602-5613.
114. Hoff, S.D., Matsushita, Y., Ota, D.M., Cleary, K.R., Yamori, T., Hakomori, S., and Irimura, T. 1989. Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res 49:6883-6888.
115. Hoff, S.D., Irimura, T., Matsushita, Y., Ota, D.M., Cleary, K.R., and Hakomori, S. 1990. Metastatic potential of colon carcinoma. Expression of ABO/Lewis-related antigens. Arch Surg 125:206-209.
116. Holmberg, L.A., and Sandmaier, B.M. 2004. Vaccination with Theratope (STn-KLH) as treatment for breast cancer. Expert Rev Vaccines 3:655-663.
117. Holt, G.D., and Hart, G.W. 1986. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem 261:8049-8057.
118. Homeister, J.W., Thall, A.D., Petryniak, B., Maly, P., Rogers, C.E., Smith, P.L., Kelly, R.J., Gersten, K.M., Askari, S. W., Cheng, G. et al. 2001. The alpha(1,3)fucosyltransferases FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 15:115-126.
119. Humphries, D.E., and Silbert, J.E. 1988. Chlorate: a reversible inhibitor of proteoglycan sulfation. Biochem Biophys Res Commun 154:365-371.
120. Ikegami-Kuzuhara, A., Yoshinaka, T., Ohmoto, H., Inoue, Y., and Saito, T. 2001. Therapeutic potential of a novel synthetic selectin blocker, OJ-R9188, in allergic dermatitis. Br J Pharmacol 134:1498-1504.
121. Inatani, M., Irie, F., Plump, A.S., Tessier-Lavigne, M., and Yamaguchi, Y. 2003. Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 302:1044-1046.
122. Ingale, S., Wolfert, M.A., Gaekwad, J., Buskas, T., and Boons, G.J. 2007. Robust immune responses elicited by a fully synthetic three-component vaccine. Nat Chem Biol 3:663-667.
123. Iozzo, R.V., and Clark, C.C. 1987. Modulation of heparan sulfate biosynthesis. Effects of 6-diazo-5-oxo-L-norleucine and low glutamine on the synthesis of heparan sulfate proteoglycan by human colon carcinoma cells. J Biol Chem 262:11188-11199.
124. Ishibashi, Y., Nakasone, T., Kiyohara, M., Horibata, Y., Sakaguchi, K., Hijikata, A., Ichinose, S., Omori, A., Yasui, Y., Imamura, A. et al. 2007. A novel endoglycoceramidase hydrolyzes oligogalactosylceramides to produce galactooligosaccharides and ceramides. J Biol Chem 282:11386-11396.
125. Itano, N., and Kimata, K. 2002. Mammalian hyaluronan synthases. IUBMB Life 54:195-199.
126. Ito, M., Ikegami, Y., and Yamagata, T. 1993. Kinetics of endoglycoceramidase action toward cell-surface glycosphingolip ids of erythrocytes. Eur J Biochem 218:645-649.
127. Ito, M., and Komori, H. 1996. Homeostasis of cell-surface glycosphingolipid content in B16 melanoma cells - Evidence revealed by an endoglycoceramidase. J Biol Chem 271:12655-12660.
128. Iyer, S.P., Akimoto, Y., and Hart, G.W. 2003. Identification and cloning of a novel family of coiled-coil domain proteins that interact with O-GlcNAc transferase. J Biol Chem 278:5399-5409.
129. Iyer, S.P., and Hart, G.W. 2003. Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. J Biol Chem 278:24608-24616.
130. Izumi, J., Takagaki, K., Nakamura, T., Shibata, S., Kojima, K., Kato, I., and Endo, M. 1994. A novel oligosaccharide, xylosylβ1-4xylosylβ1-(4- methylumbelliferone), synthesized by cultured human skin fibroblasts in the presence of 4-methylumbelliferyl-β-D-xyloside. J Biochem (Tokyo) 116:524-529.
131. Izumi, M., Wada, K., Yuasa, H., and Hashimoto, H. 2005. Synthesis of bisubstrate and donor analogues of sialyltransferase and their inhibitory activities. J Org Chem 70:8817-8824.
132. Izumi, M., Kaneko, S., Yuasa, H., and Hashimoto, H. 2006. Synthesis of bisubstrate analogues targeting alpha-1,3-fucosyltransferase and their activities. Org Biomol Chem 4:681-690.
133. Jeyakumar, M., Butters, T.D., Cortina-Borja, M., Hunnam, V., Proia, R.L., Perry, V.H., Dwek, R. A., and Platt, F. M. 1999. Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci USA 96:6388-6393.
134. Jung, K.-H., and Schmidt, R.R. 2003. Glycosyltransferse Inhibitors. In: Carbohydrate-Based Drug Discovery Wong, C.-H., Ed., Weinheim: Wiley-VCH, 609-660.
135. Kajihara, Y., Hashimoto, H., and Kodama, H. 1992. Methyl-3-O-(2- acetamido-2-deoxy-6-thio-beta-D-glucopyranosyl)-beta-D-galactopyranoside: a slow reacting acceptor-analogue which inhibits glycosylation by UDP-D-galactose-N- acetyl-D-glucosamine-(1-4)-beta-D-galactosyltransferase. Carbohydr Res 229:C5-C9.
136. Kajihara, Y., Kodama, H., Wakabayashi, T., Sato, K., and Hashimoto, H. 1993. Characterization of inhibitory activities and binding mode of synthetic 6′-modified methyl N-acetyl-β-lactosaminide toward rat liver CMP-D-Neu5Ac: D-galactoside-(2→6)-α-D-sialyltransferase. Carbohydr Res 247:179-193.
137. Kamimura, K., Koyama, T., Habuchi, H., Ueda, R., Masu, M., Kimata, K., and Nakato, H. 2006. Specific and flexible roles of heparan sulfate modifications in Drosophila FGF signaling. J Cell Biol 174:773-778.
138. Kantor, D.B., Chivatakarn, O., Peer, K.L., Oster, S.F., Inatani, M., Hansen, M.J., Flanagan, J.G., Yamaguchi, Y., Sretavan, D.W., Giger, R.J. et al. 2004. Semaphorin 5A is a bifunctional axon guidance cue regulated by heparan and chondroitin sulfate proteoglycans. Neuron 44:961-975.
139. Kawagoe, K., Kitamura, D., Okabe, M., Taniuchi, I., Ikawa, M., Watanabe, T., Kinoshita, T., and Takeda, J. 1996. Glycosylphosphatidylinositol-anchor- deficient mice: Implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood 87:3600-3606.
140. Kean, E.L., and Wei, Z. 1998. Stimulation as well as inhibition by antibiotics of the formation of GlcNAc-lipids of the dolichol pathway. Glycoconj J 15:405-414.
141. Kehoe, J.W., Maly, D.J., Verdugo, D.E., Armstrong, J.I., Cook, B.N., Ouyang, Y.B., Moore, K.L., Ellman, J.A., and Bertozzi, C.R. 2002. Tyrosylprotein sulfotransferase inhibitors generated by combinatorial target-guided ligand assembly. Bioorg Med Chem Lett 12:329-332.
142. Kelleher, D.J., and Gilmore, R. 2006. An evolving view of the eukaryotic oligosaccharyltransferase. Glycobiology 16:47R-62R.
143. Keller, K.M., Brauer, P.R., and Keller, J.M. 1989. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28:8100-8107.
144. Kelly, M., Hwang, J.M., and Kubes, P. 2007. Modulating leukocyte recruitment in inflammation. J Allergy Clin Immunol 120:3-10.
145. Khan, S.H., Crawley, S.C., Kanie, O., and Hindsgaul, O. 1993. A trisaccharide acceptor analog for N-acetylglucosaminyltransferase V which binds to the enzyme but sterically precludes the transfer reaction. J Biol Chem 268:2468-2473.
146. Kilpatrick, D.C. 2002. Animal lectins: a historical introduction and overview. Biochim Biophys Acta 1572:187-197.
147. Kim, Y.J., Borsig, L., Varki, N.M., and Varki, A. 1998. P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci USA 95:9325-9330.
148. Kim, Y.J., Borsig, L., Han, H.L., Varki, N.M., and Varki, A. 1999. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 155:461-472.
149. Kinoshita-Toyoda, A., Yamada, S., Haslam, S.M., Khoo, K.H., Sugiura, M., Morris, H.R., Dell, A., and Sugahara, K. 2004. Structural determination of five novel tetrasaccharides containing 3-O-sulfated D-glucuronic acid and two rare oligosaccharides containing a beta-D-glucose branch isolated from squid cartilage chondroitin sulfate E. Biochemistry 43:11063-11074.
150. Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Buchler, M.W., Lander, A.D., and Korc, M. 1998. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 102:1662-1673.
151. Kleeff, J., Wildi, S., Kumbasar, A., Friess, H., Lander, A.D., and Korc, M. 1999. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas 19:281-288.
152. Kojima, N., Handa, K., Newman, W., and Hakomori, S. 1992. Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochem Biophys. Res Commun 182:1288-1295.
153. Kolter, T., Proia, R. L., and Sandhoff, K. 2002. Combinatorial ganglioside biosynthesis. J Biol Chem 277:25859-25862.
154. Konrad, R.J., Zhang, F.X., Hale, J.E., Knierman, M.D., Becker, G.W., and Kudlow, J.E. 2002. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun 293:207-212.
155. Kreppel, L.K., Blomberg, M.A., and Hart, G.W. 1997. Dynamic glycosylation of nuclear and cytosolic proteins - Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 272:9308-9315.
156. Kreuger, J., Spillmann, D., Li, J.P., and Lindahl, U. 2006. Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 174:323-327.
157. Krug, L.M., Ragupathi, G., Hood, C., Kris, M.G., Miller, V.A., Allen, J.R., Keding, S.J., Danishefsky, S.J., Gomez, J., Tyson, L. et al. 2004. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin. Clin Cancer Res 10:6094-6100.
158. Krug, L.M., Ragupathi, G., Ng, K.K., Hood, C., Jennings, H.J., Guo, Z., Kris, M.G., Miller, V., Pizzo, B., Tyson, L. et al. 2004. Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin. Clin Cancer Res 10:916-923.
159. Kuan, S.F., Byrd, J.C., Basbaum, C., and Kim, Y.S. 1989. Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. J Biol Chem 264:19271-19277.
160. Laferte, S., Chan, N.W., Sujino, K., Lowary, T.L., and Palcic, M. M. 2000. Intracellular inhibition of blood group A glycosyltransferase. Eur J Biochem 267:4840-4849.
161. Lai, J., Chien, J., Staub, J., Avula, R., Greene, E.L., Matthews, T.A., Smith, D.I., Kaufmann, S.H., Roberts, L.R., and Shridhar, V. 2003. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem 278:23107-23117.
162. Ledeen, R.W. 1984. Biology of gangliosides: neuritogenic and neuronotrophic properties. J Neurosci Res. 12:147-159.
163. Ledeen, RW., Wu, G., Lu, Z.H., Kozireski-Chuback, D., and Fang, Y. 1998. The role of GM1 and other gangliosides in neuronal differentiation. Overview and new finding. Ann N Y Acad Sci 845:161-175.
164. Lee, L., Abe, A., and Shayman, J.A. 1999. Improved inhibitors of glucosylceramide synthase. J Biol Chem 274:14662-14669.
165. Lieberman, R.L., Wustman, B.A., Huertas, P., Powe, A.C., Jr., Pine, C.W., Khanna, R., Schlossmacher, M.G., Ringe, D., and Petsko, G.A. 2007. Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease. Nat Chem Biol 3:101-107.
166. Lin, X., Wei, G., Shi, Z.Z., Dryer, L., Esko, J.D., Wells, D.E., and Matzuk, M.M. 2000. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev Biol 224:299-311.
167. Linhardt, R.J., Turnbull, J.E., Wang, H.M., Loganathan, D., and Gallagher, J.T. 1990. Examination of the substrate specificity of heparin and heparan sulfate lyases. Biochemistry 29:2611-2617.
168. Linhardt, R.J., Avci, F.Y., Toida, T., Kim, Y.S., and Cygler, M. 2006. CS lyases: structure, activity, and applications in analysis and the treatment of diseases. Adv Pharmacol 53:187-215.
169. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G.W., and Gong, C.X. 2004. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci USA 101:10804-10809.
170. Llaneza, A., Vizoso, F., Rodriguez, J.C., Raigoso, P., Garcia-Muniz, J.L., Allende, M.T., and Garcia-Moran, M. 2000. Hyaluronic acid as prognostic marker in resectable colorectal cancer. Br J Surg 87:1690-1696.
171. Locci, P., Becchetti, E., Venti, G., Lilli, C., Marinucci, L., Donti, E., Paludetti, G., and Maurizi, M. 1996. Glycosaminoglycan metabolism in otosclerotic bone cells. Biol Cell 86:73-78.
172. Lowary, T.L., and Hindsgaul, O. 1993. Recognition of synthetic deoxy and deoxyfluoro analogs of the acceptor alpha-L-Fucp-(1→2)-beta-D-Galp-OR by the blood-group A and B gene-specified glycosyltransferases. Carbohydr Res 249:163-195.
173. Lowary, T.L., and Hindsgaul, O. 1994. Recognition of synthetic O-methyl, epimeric, and amino analogues of the acceptor alpha-L-Fucp-(1 → 2)-beta-D-Galp-OR by the blood-group A and B gene-specified glycosyltransferases. Carbohydr Res 251:33-67.
174. Lowary, T.L., Swiedler, S.J., and Hindsgaul, O. 1994. Recognition of synthetic analogues of the acceptor, β-D-Galp-OR, by the blood-group H gene-specified glycosyltransferase. Carbohydr Res 256:257-273.
175. Lowe, J.B., and Marth, J.D. 2003. A genetic approach to mammalian glycan function. Annu Rev Biochem 72:643-691.
176. Lu, L., and Stanley, P. 2006. Roles of O-fucose glycans in notch signaling revealed by mutant mice. Methods Enzymol. 417:127-136.
177. Lu, P.P., Hindsgaul, O., Li, H., and Palcic, M.M. 1997. Synthesis and evaluation of eight aminodeoxy trisaccharide inhibitors for N- acetylglucosaminyltransferase-V. Carbohydr Res 303:283-291.
178. Ludwig, R.J., Alban, S., Bistrian, R., Boehncke, W.H., Kaufmann, R., Henschler, R., and Gille, J. 2006. The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo. Thromb Haemost 95:535-540.
179. MacArthur, J.M., Bishop, J.R., Wang, L., Stanford, K.I., Bensadoun, A., Witztum, J.L., and Esko, J.D. 2007. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest 117:153-164.
180. Macauley, M.S., Whitworth, G.E., Debowski, A.W., Chin, D., and Vocadlo, D.J. 2005. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J Biol Chem 280:25313-25322.
181. Maley, F., Trimble, R.B., Tarentino, A.L., and Plummer, T.H., Jr. 1989. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem 180:195-204.
182. Maly, P., Thall, A., Petryniak, B., Rogers, C.E., Smith, P.L., Marks, R.M., Kelly, R.J., Gersten, K.M., Cheng, G., Saunders, T.L. et al. 1996. The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 86:643-653.
183. Mann, K.J., and Sevlever, D. 2001. 1,10-phenanthroline inhibits glycosylphosphatidylinositol anchoring by preventing phosphoethanolamine addition to glycosylphosphatidylinositol anchor precursors. Biochemistry 40:1205-1213.
184. 1H NMR analysis using a nano-NMR probe indicates the presence of a terminal α-GalNAc residue capping 4-methylumbelliferyl-β-D-xylosides. J Biol Chem 270:9154-9163.
185. Marionneau, S., Cailleau-Thomas, A., Rocher, J., Le Moullac-Vaidye, B., Ruvoen, N., Clement, M., and Le Pendu, J. 2001. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 83:565-573.
186. Marshall, S., Bacote, V., and Traxinger, R.R. 1991. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712.
187. Matsuda, K., Maruyama, H., Guo, F., Kleeff, J., Itakura, J., Matsumoto, Y., Lander, A.D., and Korc, M. 2001. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61:5562-5569.
188. Miao, H.-Q., Fritz, T.A., Esko, J.D., Zimmermann, J., Yayon, A., and Vlodavsky, I. 1995. Heparan sulfate primed on β-D-xylosides restores binding of basic fibroblast growth factor. J Cell Biochem 57:173-184.
189. Mitchell, M.L., Tian, F., Lee, L.V., and Wong, C.H. 2002. Synthesis and evaluation of transition-state analogue inhibitors of alpha-1,3- fucosyltransferase. Angew Chem Int Ed Engl 41:3041-3044.
190. Miura, Y., Kim, S., Etchison, J.R., Ding, Y.L., Hindsgaul, O., and Freeze, H.H. 1999. Aglycone structure influences α-fucosyltransferase III activity using N-acetyllactosamine glycoside acceptors. Glycoconjugate J 16:725-730.
191. Mong, T.K., Lee, L.V., Brown, J.R., Esko, J.D., and Wong, C.H. 2003. Synthesis of N-acetyllactosamine derivatives with variation in the aglycon moiety for the study of inhibition of sialyl Lewis x expression. Chembiochem 4:835-840.
192. Morad, N., Ryser, H.J., and Shen, W.C. 1984. Binding sites and endocytosis of heparin and polylysine are changed when the two molecules are given as a complex to Chinese hamster ovary cells. Biochim Biophys Acta 801:117-126.
193. Moremen, K.W., and Molinari, M. 2006. N-linked glycan recognition and processing: the molecular basis of endoplasmic reticulum quality control. Curr Opin Struct Biol 16:592-599.
194. Mukherjee, A., Palcic, M.M., and Hindsgaul, O. 2000. Synthesis and enzymatic evaluation of modified acceptors of recombinant blood group A and B glycosyltransferases. Carbohydr Res 326:1-21.
195. Murray, B.W., Takayama, S., Schultz, J., and Wong, C.H. 1996. Mechanism and specificity of human alpha-1,3-fucosyltransferase V. Biochemistry 35:11183-11195.
196. Nakagoe, T., Fukushima, K., Hirota, M., Kusano, H., Ayabe, H., Tomita, M., and Kamihira, S. 1993. Immunohistochemical expression of sialyl Lex antigen in relation to survival of patients with colorectal carcinoma. Cancer 72:2323-2330.
197. Nakajima, H., Miura, Y., and Yamagata, T. 1998. Glycosylation of amphipathic lactoside primers with consequent inhibition of endogenous glycosphingolipid synthesis
198. Glycosylation of lactosylceramide analogs in animal cells: amphipathic disaccharide primers for glycosphingolipid synthesis. J Biochem (Tokyo) 124:148-156.
199. χ antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study. Cancer Res 53:3632-3637.
200. Nakamori, S., Kameyama, M., Imaoka, S., Furukawa, H., Ishikawa, O., Sasaki, Y., Izumi, Y., and Irimura, T. 1997. Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis Colon Rectum 40:420-431.
201. Nakamura, T., Izumi, J., Takagaki, K., Shibata, S., Kojima, K., Kato, I., and Endo, M. 1994. A novel oligosaccharide, GlcAβ1-4Xylβ1-(4- methylumbelliferone), synthesized by human cultured skin fibroblasts. Biochem J 304:731-736.
202. Neville, D.C.A., Field, R.A., and Ferguson, M.A.J. 1995. Hydrophobic glycosides of N-acetylglucosamine can act as primers for polylactosamine synthesis and can affect glycolipid synthesis in vivo. Biochem J 307:791-797.
203. Niers, T.M., Klerk, C.P., DiNisio, M., Van Noorden, C.J., Buller, H.R., Reitsma, P.H., and Richel, D.J. 2007. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit Rev Oncol Hematol 61:195-207.
204. Norris, A.J., Whitelegge, J.P., Strouse, M.J., Faull, K.F., and Toyokuni, T. 2004. Inhibition kinetics of carba- and C-fucosyl analogues of GDP-fucose against fucosyltransferase V: implication for the reaction mechanism. Bioorg Med Chem Lett 14:571-573.
205. O'Donnell, N., Zachara, N.E., Hart, G.W., and Marth, J.D. 2004. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 24:1680-1690.
206. Okayama, M., Kimata, K., and Suzuki, S. 1973. The influence of p-nitrophenyl β-D-xyloside on the synthesis of proteochondroitin sulfate by slices of embryonic chick cartilage. J.Biochem.(Tokyo) 74:1069-1073.
207. Orlean, P., and Menon, A.K. 2007. Thematic review series: lipid post-translational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids. J Lipid Res 48:993-1011.
208. Palcic, M.M., Heerze, L.D., Srivastava, O.P., and Hindsgaul, O. 1989. A bisubstrate analog inhibitor for alpha(1-2)-fucosyltransferase. J Biol Chem 264:17174-17181.
209. Palcic, M.M., Ripka, J., Kaur, K.J., Shoreibah, M., Hindsgaul, O., and Pierce, M. 1990. Regulation of N-acetylglucosaminyltransferase V activity. Kinetic comparisons of parental, Rous sarcoma virus-transformed BHK, and L-phytohemagglutinin-resistant BHK cells using synthetic substrates and an inhibitory substrate analog. J Biol Chem 265:6759-6769.
210. Paulsen, H., Springer, M., Reck, F., Brockhausen, I., and Schachter, H. 1995. Synthesis of modified tetrasaccharides as acceptor-inhibitor analogs of N-acetylglucosaminyltransferase II. Carbohydr Res 275:403-411.
211. Pazur, J.H. 1998. Anti-carbohydrate antibodies with specificity for monosaccharide and oligosaccharide units of antigens. Adv Carbohydr Chem Biochem 53:201-261.
212. Platt, F.M., Neises, G.R., Dwek, R.A., and Butters, T.D. 1994. N-Butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem 269:8362-8365.
213. Platt, F.M., Neises, G.R., Reinkensmeier, G., Townsend, M.J., Perry, V.H., Proia, R.L., Winchester, B., Dwek, R.A., and Butters, T.D. 1997. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 276:428-431.
214. Platt, F.M., Reinkensmeier, G., Dwek, R.A., and Butters, T.D. 1997. Extensive glycosphingolipid depletion in the liver and lymphoid organs of mice treated with N-butyldeoxynojirimycin. J Biol Chem 272:19365-19372.
215. Portmann, A.F., and Holden, W.D. 1949. Protamine sulphate, heparin, and blood coagulation. J Clin Invest 28:1451-1458.
216. Ragupathi, G., Gathuru, J., and Livingston, P. 2005. Antibody inducing polyvalent cancer vaccines. Cancer Treat Res 123:157-180.
217. Ralton, J.E., Milne, K.G., Guther, M.L., Field, R.A., and Ferguson, M.A. 1993. The mechanism of inhibition of glycosylphosphatidylinositol anchor biosynthesis in Trypanosoma brucei by mannosamine. J Biol Chem 268:24183-24189.
218. Ranes, M.K., El-Abbadi, M., Manfredi, M.G., Mukherjee, P., Platt, F.M., and Seyfried, T.N. 2001. N-butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer 84:1107-1114.
219. Reck, F., Meinjohanns, E., Springer, M., Wilkens, R., Van Dorst, J.A.L.M., Paulsen, H., Möller, G., Brockhausen, I., and Schachter, H. 1994. Synthetic substrate analogues for UDP-GlcNAc:Manα1-6R β(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzyme. Glycoconjugate J 11:210-216.
220. Reck, F., Springer, M., Meinjohanns, E., Paulsen, H., Brockhausen, I., and Schachter, H. 1995. Synthetic substrate analogues for UDP-GlcNAc: Manα;1-3R β1-2-N-acetylglucosaminyltransferase 1. Substrate specificity and inhibitors for the enzyme. Glycoconjugate J 12:747-754.
221. Ringvall, M., Ledin, J., Holmborn, K., Van Kuppevelt, T., Ellin, F., Eriksson, I., Olofsson, A. M., Kjellén, L., and Forsberg, E. 2000. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem 275:25926-25930.
222. Roberts, A.L., Thomas, B.J., Wilkinson, A.S., Fletcher, J.M., and Byers, S. 2006. Inhibition of glycosaminoglycan synthesis using rhodamine B in a mouse model of mucopolysaccharidosis type IIIA. Pediatr Res 60:309-314.
223. Robinson, C.J., Mulloy, B., Gallagher, J.T., and Stringer, S.E. 2006. VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J Biol Chem 281:1731-1740.
224. Robinson, K.A., Ball, L.E., and Buse, M.G. 2007. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 292:E884-890.
225. Rosen, S.D. 2004. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22:129-156.
226. Rüdiger, H. 1998. Plant lectins - More than just tools for glycoscientists: Occurrence, structure, and possible functions of plant lectins. Acta Anat.(Basel) 161:130-152.
227. Sabbatini, P.J., Ragupathi, G., Hood, C., Aghajanian, C.A., Juretzka, M., Iasonos, A., Hensley, M.L., Spassova, M.K., Ouerfelli, O., Spriggs, D.R. et al. 2007. Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer. Clin Cancer Res 13:4170-4177.
228. Safaiyan, F., Kolset, S.O., Prydz, K., Gottfridsson, E., Lindahl, U., and Salmivirta, M. 1999. Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem 274:36267-36273.
229. Salimath, P.V., Spiro, R.C., and Freeze, H.H. 1995. Identification of a novel glycosaminoglycan core-like molecule II. α-GalNAc-capped xylosides can be made by many cell types. J Biol Chem 270:9164-9168.
230. Sansom, C., and Markman, O. 2007. Glycobiology. Scion Publishing Ltd
231. Sarkar, A.K., and Esko, J.D. 1995. Synthesis and glycosaminoglycan priming activity of three disaccharides related to the linkage region tetrasaccharide of proteoglycans. Carbohyd Res 279:161-171.
232. Sarkar, A.K., Fritz, T.A., Taylor, W.H., and Esko, J.D. 1995. Disaccharide uptake and priming in animal cells: Inhibition of sialyl Lewis X by acetylated Galbeta1,4GlcNAcbeta-O-naphthalenemethanol. Proc Natl Acad Sci USA 92:3323-3327.
233. X inhibit selectin-mediated cell adhesion. J Biol Chem 272:25608-25616.
234. Sarkar, A.K., Brown, J.R., and Esko, J.D. 2000. Synthesis and glycan priming activity of acetylated disaccharides. Carbohydr Res 329:287-300.
235. Schick, B.P., Maslow, D., Moshinski, A., and San Antonio, J.D. 2004. Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo. Blood 103:1356-1363.
236. Schnaar, R.L. 2000. Glycobiology of The Nervous System. In: Carbohydrates in Chemistry and Biology 1013 Ernst, B., Hart, G. W. and Sinaÿ, P., Eds., Weinheim: Wiley-VCH.
237. Schrag, J.D., Procopio, D.O., Cygler, M., Thomas, D.Y., and Bergeron, J.J. 2003. Lectin control of protein folding and sorting in the secretory pathway. Trends Biochem Sci 28:49-57.
238. Schuksz, M., Fuster, M.M., Brown, J.R., Crawford, B.E., Ditto, D.P., Lawrence, R., Glass, C.A., Wang, L., Elson-Schwab, L., Tor, Y. et al. 2007. Surfen - a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci USA , in press.
239. Schultz, C., Vajanaphanich, M., Harootunian, A.T., Sammak, P.J., Barrett, K.E., and Tsien, R.Y. 1993. Acetoxymethyl esters of phosphates, enhancement of the permeability and potency of cAMP. J Biol Chem 268:6316-6322.
240. Schwartz, N.B., Galligani, L., Ho, P.-L., and Dorfman, A. 1974. Stimulation of synthesis of free chondroitin sulfate chains by β-D-xylosides in cultured cells. Proc Natl Acad Sci USA 71:4047-4051.
241. Schwarz, R.T., and Datema, R. 1982. The lipid pathway of protein glycosylation and its inhibitors: the biological significance of protein-bound carbohydrates. Adv Carbohydr Chem Biochem 40:287-379.
242. Schwörer, R., and Schmidt, R.R. 2002. Efficient sialyltransferase inhibitors based on glycosides of N-acetylglucosamine. J Am Chem Soc 124:1632-1637.
243. Sevlever, D., and Rosenberry, T.L. 1993. Mannosamine inhibits the synthesis of putative glycoinositol phospholipid anchor precursors in mammalian cells without incorporating into an accumulated intermediate. J Biol Chem 268:10938-10945.
244. Sevlever, D., Mann, K.J., and Medof, M.E. 2001. Differential effect of 1,10-phenanthroline on mammalian, yeast, and parasite glycosylphosphatidylinositol anchor synthesis. Biochem Biophys Res Commun 288:1112-1118.
245. Shafi, R., Iyer, S.P., Ellies, L.G., O'Donnell, N., Marek, K.W., Chui, D., Hart, G.W., and Marth, J.D. 2000. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci USA 97:5735-5739.
246. Shao, L., Luo, Y., Moloney, D.J., and Haltiwanger, R. 2002. O-glycosylation of EGF repeats: identification and initial characterization of a UDP-glucose: protein O-glucosyltransferase. Glycobiology 12:763-770.
247. Sharma, B., Handler, M., Eichstetter, I., Whitelock, J.M., Nugent, M.A., and Iozzo, R.V. 1998. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J Clin Invest 102:1599-1608.
248. Sharma, D.K., Smith, T.K., Weller, C.Z., Crossman, A., Brimacombe, J.S., and Ferguson, M.A.J. 1999. Differences between the trypanosomal and human GlcNAc-PI de-N-acetylases of glycosylphosphatidylinositol membrane anchor biosynthesis. Glycobiology 9:415-422.
249. Sharon, N. 2006. Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta 1760:527-537.
250. Sheikh, K.A., Sun, J., Liu, Y., Kawai, H., Crawford, T.O., Proia, R.L., Griffin, J.W., and Schnaar, R. L. 1999. Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci USA 96:7532-7537.
251. Shibata, S., Takagaki, K., Nakamura, T., Izumi, J., Kojima, K., Kato, I., and Endo, M. 1995. HNK-1-reactive novel oligosaccharide, sulfate-O-3GlcAβ1-4Xylβ1-(4-methylumbelliferone), synthesized by cultured human skin fibroblasts. J Biol Chem 270:13794-13798.
252. Shirota, K., Kato, Y., Irimura, T., Kondo, H., and Sugiyama, Y. 2001. Anti-metastatic effect of the sialyl Lewis-X analog GSC-150 on the human colon carcinoma derived cell line KM12-HX in the mouse. Biol Pharm Bull 24:316-319.
253. Skropeta, D., Schworer, R., and Schmidt, R. R. 2003. Stereoselective synthesis of phosphoramidate alpha(2-6)sialyltransferase transition-state analogue inhibitors. Bioorg Med Chem Lett 13:3351-3354.
254. Smith, T.K., Sharma, D.K., Crossman, A., Dix, A., Brimacombe, J.S., and Ferguson, M.A.J. 1997. Parasite and mammalian GPI biosynthetic pathways can be distinguished using synthetic substrate analogues. EMBO J 16:6667-6675.
255. Smith, T.K., Sharma, D.K., Crossman, A., Brimacombe, J.S., and Ferguson, M.A.J. 1999. Selective inhibitors of the glycosylphosphatidylinositol biosynthetic pathway of Trypanosoma brucei. EMBO J 18:5922-5930.
256. Smith, T.K., Crossman, A., Borissow, C.N., Paterson, M.J., Dix, A., Brimacombe, J.S., and Ferguson, M.A.J. 2001. Specificity of GlcNAc-Pl de-N-acetylase of GPI biosynthesis and synthesis of parasite-specific suicide substrate inhibitors. EMBO J 20:3322-3332.
257. Smith, T.K., Gerold, P., Crossman, A., Paterson, M.J., Borissow, C.N., Brimacombe, J.S., Ferguson, M.A., and Schwarz, R.T. 2002. Substrate specificity of the Plasmodium falciparum glycosylphosphatidylinositol biosynthetic pathway and inhibition by species-specific suicide substrates. Biochemistry 41:12395-12406.
258. Smith, T.K., Crossman, A., Brimacombe, J.S., and Ferguson, M.A. 2004. Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness. Embo J 23:4701-4708.
259. Snapp, K.R., Heitzig, C.E., Ellies, L.G., Marth, J.D., and Kansas, G.S. 2001. Differential requirements for the O-linked branching enzyme core 2 beta1-6-N-glucosaminyltransferase in biosynthesis of ligands for E-selectin and P-selectin. Blood 97:3806-3811.
260. Spiro, R.C., Parsons, W.G., Perry, S.K., Caufield, J.P., Hein, A., Reisfeld, R.A., Harper, J. R., Austen, K. F., and Stevens, R. L. 1986. Inhibition of post-translational modification and surface expression of a melanoma-associated chondroitin sulfate proteoglycan by diethylcarbamazine or ammonium chloride. J Biol Chem 261:5121-5129.
261. Spiro, R.C., Freeze, H.H., Sampath, D., and Garcia, J.A. 1991. Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by Brefeldin A. J Cell Biol 115:1463-1473.
262. Steet, R., Chung, S., Lee, W.S., Pine, C.W., Do, H., and Kornfeld, S. 2007. Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-beta-glucosidase. Biochem Pharmacol 73:1376-1383.
263. Stern, R., Asari, A.A., and Sugahara, K.N. 2006. Hyaluronan fragments: An information-rich system. Eur J Cell Biol 85:699-715.
264. Stevens, R.L., Parsons, W.G., Austen, K.F., Hein, A., and Caulfield, J.P. 1985. Novel inhibition of proteoglycan synthesis and exocytosis by diethylcarbamazine in the swarm rat chondrocyte. J Biol Chem 260:5777-5786.
265. Stickens, D., Zak, B.M., Rougier, N., Esko, J.D., and Werb, Z. 2005. Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132:5055-5068.
266. Stuhlmeier, K.M. 2006. Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule.Wien Med Wochenschr 156:563-568.
267. Suganuma, R., Walden, C.M., Butters, T.D., Platt, F.M., Dwek, R.A., Yanagimachi, R., and van der Spoel, A.C. 2005. Alkylated imino sugars, reversible male infertility-inducing agents, do not affect the genetic integrity of male mouse germ cells during short-term treatment despite induction of sperm deformities. Biol Reprod 72:805-813.
268. Sütterlin, C., Horvath, A., Gerold, P., Schwarz, R.T., Wang, Y., Dreyfuss, M., and Riezman, H. 1997. Identification of a species-specific inhibitor of glycosylphosphatidylinositol synthesis. EMBO J 16:6374-6383.
269. Szkudelski, T. 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546.
270. Takami, N., Oda, K., and Ikehara, Y. 1992. Aberrant processing of alkaline phosphatase precursor caused by blocking the synthesis of glycosylphosphatidylinositol. J Biol Chem 267:1042-1047.
271. Takamiya, K., Yamamoto, A., Furukawa, K., Yamashiro, S., Shin, M., Okada, M., Fukumoto, S., Haraguchi, M., Takeda, N., Fujimura, K. et al. 1996. Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc Natl Acad Sci USA 93:10662-10667.
272. Takayama, S., Chung, S.J., Igarashi, Y., Ichikawa, Y., Sepp, A., Lechler, R.I., Wu, J., Hayashi, T., Siuzdak, G., and Wong, C. H. 1999. Selective inhibition of beta-1,4- and alpha-1,3-galactosyltransferases: donor sugar-nucleotide based approach. Bioorg Med Chem 7:401-409.
273. Tarentino, A.L., and Plummer, T.H., Jr. 1994. Enzymatic deglycosylation of asparagine-linked glycans: Purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Meth in Enzymol 230:44-57.
274. Taylor, M.E., and Drickamer, K. 2003. Introduction to Glycobiology. Oxford: Oxford University Press: Oxford.
275. Ten Hagen, K.G., Fritz, T.A., and Tabak, L.A. 2003. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13:1R-16R.
276. Tian, E., Hagen, K.G., Shum, L., Hang, H.C., Imbert, Y., Young, W.W., Jr., Bertozzi, C.R., and Tabak, L.A. 2004. An inhibitor of O-glycosylation induces apoptosis in NIH3T3 cells and developing mouse embryonic mandibular tissues. J Biol Chem 279:50382-50390.
277. Tifft, C.J., and Proia, R.L. 2000. Stemming the tide: glycosphingolipid synthesis inhibitors as therapy for storage diseases. Glycobiology 10:1249-1258.
278. Tiwari, V., O'Donnell, C., Copeland, R.J., Scarlett, T., Liu, J., and Shukla, D. 2007. Soluble 3-O-sulfated heparan sulfate can trigger herpes simplex virus type 1 entry into resistant Chinese hamster ovary (CHOK1) cells. J Gen Virol 88:1075-1079.
279. Toole, B.P., Wight, T.N., and Tammi, M.I. 2002. Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277:4593-4596.
280. Toole, B.P. 2004. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528-539.
281. Uchimura, K., Kadomatsu, K., Nishimura, H., Muramatsu, H., Nakamura, E., Kurosawa, N., Habuchi, O., El-Fasakhany, F.M., Yoshikai, Y., and Muramatsu, T. 2002. Functional analysis of the chondroitin 6-sulfotransferase gene in relation to lymphocyte subpopulations, brain development, and oversulfated chondroitin sulfates. J Biol Chem 277:1443-1450.
282. Uhlin-Hansen, L., and Yanagishita, M. 1993. Differential effect of brefeldin A on the biosynthesis of heparan sulfate and chondroitin/dermatan sulfate proteoglycans in rat ovarian granulosa cells in culture. J Biol Chem 268:17370-17376.
283. Ulbrich, H.K., Luxenburger, A., Prech, P., Eriksson, E.E., Soehnlein, O., Rotzius, P., Lindbom, L., and Dannhardt, G. 2006. A novel class of potent nonglycosidic and nonpeptidic pan-selectin inhibitors.JMed Chem 49:5988-5999.
284. Urbaniak, M.D., Tabudravu, J.N., Msaki, A., Matera, K.M., Brenk, R., Jaspars, M., and Ferguson, M.A. 2006. Identification of novel inhibitors of UDP-Glc 4′-epimerase, a validated drug target for african sleeping sickness. Bioorg Med Chem Lett 16:5744-5747.
285. Valentino, L., Moss, T., Olson, E., Wang, H.J., Elashoff, R., and Ladisch, S. 1990. Shed tumor gangliosides and progression of human neuroblastoma. Blood 75:1564-1567.
286. Van den Steen, P., Rudd, P.M., Dwek, R.A., and Opdenakker, G. 1998. Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 33:151-208.
287. Varki, A. 1994. Selectin ligands. Proc Natl Acad Sci USA 91:7390-7397.
288. Varki, A. 1997. Selectin ligands: Will the real ones please stand up? J Clin Invest 99:158-162.
289. Varki, A., Cummings, R., Esko, J.D., Freeze, H., Hart, G.W., and Marth, J. 1999. Essentials of Glycobiology. New York: Cold Spring Harbor Laboratories Press.
290. Varki, A., and Angata, T. 2006. Siglecs - the major subfamily of I-type lectins. Glycobiology 16:1R-27R.
291. Verdugo, D.E., and Bertozzi, C.R. 2002. A 96-well dot-blot assay for carbohydrate sulfotransferases. Anal Biochem 307:330-336.
292. Volpi, N. 2006. Therapeutic applications of glycosaminoglycans. Curr Med Chem 13:1799-1810.
293. Vosseller, K., Wells, L., Lane, M.D., and Hart, G.W. 2002. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 99:5313-5318.
294. Wahrenbrock, M., Borsig, L., Le, D., Varki, N., and Varki, A. 2003. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112:853-862.
295. Wang, H., Julenius, K., Hryhorenko, J., and Hagen, F.K. 2007. Systematic analysis of proteoglycan modification sites in Caenorhabditis elegans by scanning mutagenesis. J Biol Chem 282:14586-14597.
296. Wang, J., and Rabenstein, D.L. 2006. Interaction of heparin with two synthetic peptides that neutralize the anticoagulant activity of heparin. Biochemistry 45:15740-15747.
297. Wang, L.C., Brown, J.R., Varki, A., and Esko, J.D. 2002. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins. J Clin Invest 110:127-136.
298. Watanabe, H., and Yamada, Y. 2002. Chondrodysplasia of gene knockout mice for aggrecan and link protein. Glycoconj J 19:269-273.
299. Weigel, P.H., and Yik, J.H.N. 2002. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta Gen Subj 1572:341-363.
300. Weiss, M., Hettmer, S., Smith, P., and Ladisch, S. 2003. Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase. Cancer Res 63:3654-3658.
301. Westerlind, U., Hagback, P., Tidback, B., Wiik, L., Blixt, O., Razi, N., and Norberg, T. 2005. Synthesis of deoxy and acylamino derivatives of lactose and use of these for probing the active site of Neisseria meningitidis N-acetylglucosaminyltransferase. Carbohydr Res 340:221-233.
302. Whisenhunt, T.R., Yang, X., Bowe, D. B., Paterson, A.J., Van Tine, B.A., and Kudlow, J.E. 2006. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16:551-563.
303. Whitworth, G.E., Macauley, M.S., Stubbs, K.A., Dennis, R.J., Taylor, E.J., Davies, G.J., Greig, I.R., and Vocadlo, D. J. 2007. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. J Am Chem Soc 129:635-644.
304. Winans, K.A., and Bertozzi, C.R. 2002. An inhibitor of the human UDP-GlcNAc 4-epimerase identified from a uridine-based library: a strategy to inhibit O-linked glycosylation. Chem Biol 9:113-129.
305. Woodworth, A., and Baenziger, J.U. 2001. The man/GalNAc-4-SO4-receptor has multiple specificities and functions. Results Probl Cell Differ 33:123-138.
306. Woynarowska, B., Dimitroff, C.J., Sharma, M., Matta, K.L., and Bernacki, R.J. 1996. Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconjugate J 13:663-674.
307. Xia, L., Ju, T., Westmuckett, A., An, G., Ivanciu, L., McDaniel, J.M., Lupu, F., Cummings, R. D., and McEver, R.P. 2004. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol 164:451-459.
308. Yabushita, H., Noguchi, M., Kishida, T., Fusano, K., Noguchi, Y., Itano, N., Kimata, K., and Noguchi, M. 2004. Hyaluronan synthase expression in ovarian cancer. Oncol Rep 12:739-743.
309. Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., and Proia, R.L. 1999. A vital role for glycosphingolipid synthesis during development and differentiation. Proc Natl Acad Sci USA 96:9142-9147.
310. Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N. et al. 2003. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA 100:3445-3449.
311. Yanagishita, M., and Hascall, V.C. 1984. Metabolism of proteoglycans in rat ovarian granulosa cell culture. Multiple intracellular degradative pathways and the effect of chloroquine. J Biol Chem 259:10270-10283.
312. Yanagishita, M., and Hascall, V.C. 1985. Effects of monensin on the synthesis, transport, and intracellular degradation of proteoglycans in rat ovarian granulosa cells in culture. J Biol Chem 260:5445-5455.
313. Yang, X., Zhang, F., and Kudlow, J.E. 2002. Recruitment of O-GlcNAc Transferase to Promoters by Corepressor mSin3A. Coupling Protein O-GlcNAcylation to Transcriptional Repression. Cell 110:69-80.
314. Yip, G.W., Smollich, M., and Gotte, M. 2006. Therapeutic value of glycosaminoglycans in cancer. Mol Cancer Ther 5:2139-2148.
315. Yu, A.L., Uttenreuther-Fischer, M.M., Huang, C.S., Tsui, C.C., Gillies, S.D., Reisfeld, R.A., and Kung, F.H. 1998. Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma. J Clin Oncol 16:2169-2180.
316. Yu, Z., Sawkar, A.R., Whalen, L. J., Wong, C. H., and Kelly, J. W. 2007. Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention. J Med Chem 50:94-100.
317. Zachara, N.E., and Hart, G. W. 2006. Cell signaling, the essential role of O-GlcNAc! Biochim Biophys Acta 1761:599-617.
318. Zacharias, C., van Echten-Deckert, G., Plewe, M., Schmidt, R. R., and Sandhoff, K. 1994. A truncated epoxy-glucosylceramide uncouples glycosphingolipid biosynthesis by decreasing lactosylceramide synthase activity. J Biol Chem 269:13313-13317.
319. Zhang, L., and Esko, J. D. 1994. Amino acid determinants that drive heparan sulfate assembly in a proteoglycan. J Biol Chem 269:19295-19299.
320. Zhang, L., David, G., and Esko, J.D. 1995. Repetitive Ser-Gly sequences enhance heparan sulfate assembly in proteoglycans. J Biol Chem 270:27127-27135.
321. Zhu, X., Hsu, B.T., and Rees, D.C. 1993. Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. Structure 1:27-34.
322. Zhuang, D., Grey, A., Harris-Brandts, M., Higgins, E., Kashem, M.A., and Dennis, J.W. 1991. Characterization of O-linked oligosaccharide biosynthesis in cultured cells using paranitrophenyl alpha-D-GalNAc as an acceptor. Glycobiology 1:425-433.